BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37505764)

  • 1. Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
    Bose M; Sunder Singh S; Ganesharaja S; Chiwate AS; Hingmire SJ; Rajkumar T
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2337-2346. PubMed ID: 37505764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.
    Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ
    BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer.
    Liao GD; Kang LN; Chen W; Zhang X; Liu XY; Zhao FH; Stoler MH; Mills A; Xi MR; Qiao YL; Castle PE
    J Low Genit Tract Dis; 2015 Jul; 19(3):207-11. PubMed ID: 25171105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
    Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
    Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive double antibodies sandwich ELISA for the diagnosis and therapeutic evaluation of cervical cancer.
    Li N; Gao M; Zhou S; Zhang Y; Ding Y; Li R; Jia M; Li W; Yang H
    Int J Biol Macromol; 2023 Jan; 225():1315-1322. PubMed ID: 36435469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study.
    Mao C; Balasubramanian A; Yu M; Kiviat N; Ridder R; Reichert A; Herkert M; von Knebel Doeberitz M; Koutsky LA
    Int J Cancer; 2007 Jun; 120(11):2435-8. PubMed ID: 17294450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay for p16(INK4a) - a new triage test for the detection of cervical intraepithelial neoplasia?
    Jentschke M; Lange V; Soergel P; Hillemanns P
    Acta Obstet Gynecol Scand; 2013 Feb; 92(2):160-4. PubMed ID: 23072258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Global DNA Methylation in Cervical Intraepithelial Neoplasia and Cancerous Lesions by Pyrosequencing and Enzyme-Linked Immunosorbent Assays.
    Thumbovorn R; Bhattarakosol P; Chaiwongkot A
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):143-149. PubMed ID: 35092382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
    Dixon EP; King LM; Nelson R; Simkins SG; Knapp SL; Brough GH; Lenz KL; Henderson DT; Whitehead CM; Hessling J; Brown CA; Malinowski DP
    J Immunol Methods; 2017 Mar; 442():35-41. PubMed ID: 28093271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer.
    Ding L; Zou XJ; Ao JE; Yao AX; Cai L
    Mol Diagn Ther; 2008; 12(6):395-400. PubMed ID: 19035626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
    Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China.
    Zhang SK; Jia MM; Zhao DM; Wu ZN; Guo Z; Liu YL; Guo PP; Chen Q; Cao XQ; Liu SZ; Chen W; Sun XB
    Cancer Epidemiol; 2019 Apr; 59():123-128. PubMed ID: 30739069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies.
    Li Y; Wang W; Tian J; Zhou Y; Shen Y; Wang M; Tang L; Liu C; Zhang X; Shen F; Chen Y; Gu Y
    Technol Cancer Res Treat; 2023; 22():15330338231202650. PubMed ID: 37968933
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
    Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasensitive electrochemical immunosensor based on dual signal amplification process for p16(INK4a) cervical cancer detection in clinical samples.
    Duangkaew P; Tapaneeyakorn S; Apiwat C; Dharakul T; Laiwejpithaya S; Kanatharana P; Laocharoensuk R
    Biosens Bioelectron; 2015 Dec; 74():673-9. PubMed ID: 26201985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
    Hu R; Dong Z; Zhang K; Pan G; Li C; Cui H
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32204370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
    Singh M; Mockler D; Akalin A; Burke S; Shroyer A; Shroyer KR
    Cancer Cytopathol; 2012 Feb; 120(1):26-34. PubMed ID: 22162342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus.
    Ji P; Zhu J; Li X; Fan W; Liu Q; Wang K; Zhao J; Sun Y; Liu B; Zhou EM; Zhao Q
    J Nanobiotechnology; 2020 Mar; 18(1):44. PubMed ID: 32169061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.